SciSparc Ltd. (NASDAQ: SPRC) stock jumped 17.16% on Monday to $0.99 against a previous-day closing price of $0.84. With 2.39 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.05 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.1100 whereas the lowest price it dropped to was $0.8610. The 52-week range on SPRC shows that it touched its highest point at $6.99 and its lowest point at $0.61 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SPRC was down-trending over the past week, with a drop of -1.09%, but this was up by 19.24% over a month. Three-month performance surged to 15.01% while six-month performance fell -41.47%. The stock lost -82.80% in the past year, while it has gained 30.92% so far this year.
Float and Shares Shorts:
At present, 3.53 million SPRC shares are outstanding with a float of 3.30 million shares on hand for trading. On Oct 13, 2022, short shares totaled 0.13 million, which was 3.59% higher than short shares on Sep 14, 2022. In addition to Mr. Oz Adler C.P.A. as the firm’s CEO & CFO, Mr. Itschak Shrem serves as its Pres & Director.
Through their ownership of 10.96% of SPRC’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of SPRC, in contrast to — held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in SPRC with 3.55% of the stake, Excellence Investments Ltd. holds 113,156 shares worth 113,156. A second-largest stockholder of SPRC, UBS Securities LLC, holds 25,308 shares, controlling over 0.79% of the firm’s shares. Commonwealth Equity Services LLC is the third largest shareholder in SPRC, holding 12,005 shares or 0.38% stake.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SPRC since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SPRC analysts setting a high price target of $20.00 and a low target of $20.00, the average target price over the next 12 months is $20.00. Based on these targets, SPRC could surge 1920.2% to reach the target high and rise by 1920.2% to reach the target low. Reaching the average price target will result in a growth of 1920.2% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.15 being high and -$1.15 being low. For SPRC, this leads to a yearly average estimate of -$1.15. Based on analyst estimates, the high estimate for the next quarter is -$0.28 and the low estimate is -$0.28. The average estimate for the next quarter is thus -$0.28.